MedscapeLIVE

🧫 Access translational insights on inflammation and AML pathogenesis. 📈 Shanshan Pei, PhD reviews emerging mechanistic data at Acute Leukemia Forum, April 16—17, 2026. #ALFlive26 🔗 acuteleukemiaforum.com

🔥 Dermatology is evolving. Are you? Live from #AAD2026 join debate-driven symposia on psoriasis, cSCC & the patient journey 🏔️ 🔗 Explore the agenda: mdsc.pe/4r4Oi6S

📊 Still seeing delays in intensifying therapy for #T2D? Explore the clinical and economic impact of therapeutic inertia, and discover how AID systems can help intensify treatment safely and sooner. Plus—unlock practical strategies for implementing AID and improving CGM use through team-based care. ✨ Sign up: mdsc.pe/4rZ3e7s

🔎 Managing psoriasis in sensitive areas? Learn how to identify patients for advanced systemic/biologic therapy, assess important comorbidities, and select evidence-based treatments. 📊 Elevate your care at #AAD2026 🔗 Explore the session: mdsc.pe/4lbeyLn

📊 Evidence. 🧳 Cases. 🎬 Action. Explore practical advances in HF, CKD, antithrombotics & resistant HTN at this symposia series 🏥 Designed for real-world clinical application. 🔗 Access details: mdsc.pe/470Z5rm

📊 Advance your approach to thalassemia management. Gain insight into disease mechanisms, patient burden, evolving care needs, and novel therapeutic strategies across TDT and NTDT. 🔗 bit.ly/4aeTLBE

🧩 Advancing care in Major Depressive Disorder. Explore emerging clinical trial data, identify residual symptoms, and strengthen individualized treatment planning beyond monoamines. 💬 Elevate team communication on augmentation strategies. 👉 mdsc.pe/4u2WGGu

🔬 Optimize treatment across the transplant journey. Review conditioning regimen evidence 📊, tackle unmet needs in steroid-refractory GvHD ⚠️, and strengthen personalized management plans 🤝 for patients and families. 👉 mdsc.pe/4cG6jEX

🔥 VEXAS remains one of the most complex inflammatory hematologic syndromes. 💡 Explore management strategies with @beatalleukemia at Acute Leukemia Forum, April 16—17, 2026. #ALFlive26 🔗 mdsc.pe/47wfHri

🔥 Quick check: Are you confident managing CS long-term—beyond initial treatment? Fine-tune your approach to monitoring, therapy optimization, and multidisciplinary care. 🔗 mdsc.pe/3NqDxhu

🔍 Is surgery always the right first step for CSCC? 📖 Learn how to assess progression risk, identify patients who may not benefit from a surgical-first strategy, and build stronger multidisciplinary care plans. 📍 mdsc.pe/4bgYl2S

📊 New clinical data is redefining immunotherapy for solid tumors. Review trial results, explore the rationale for novel targets 🎯 , and assess strategies for integrating these therapies into evolving treatment paradigms. 👉 mdsc.pe/4l2qv5X

📊 New data. 💊 New therapies. 🩺 New possibilities in advanced BC care. Explore emerging clinical trial results and discover how to identify eligible patients and individualize treatment strategies. ➡ mdsc.pe/4bfTcrF

🎓 Training the next generation of pigmentary disorder experts. Explore emerging therapies, case discussions, and expert insights. 💡 Advance your clinical expertise. #PDElive26 👉 mdsc.pe/4b2Nue4

🧬 Severe aplastic anemia care is evolving. 🗯️ Explore treatment mechanisms, review emerging clinical trial data on cellular therapies, and learn how to identify patients who may benefit from these novel approaches. 👉 mdsc.pe/4rk1DIF

💥 Optimize treatment across the transplant journey. Review conditioning regimen evidence 📊, tackle unmet needs in steroid-refractory GvHD ⚠️, and strengthen personalized management plans 🤝 for patients and families. 👉 mdsc.pe/4cG6jEX

🧬 Optimizing IBD management? Explore evidence-based strategies for assessing disease severity, selecting therapies, and applying treat-to-target principles. 🎯 Elevate precision in care decisions. 🔗 mdsc.pe/407dMW4

🔍 Should CCUS and high-risk CH be treated like early MDS? 💡 Zoey Xie, MD, MS explores the emerging debate at Acute Leukemia Forum, April 16—17, 2026. #ALFlive26 🔗 mdsc.pe/47wfHri

💬 How do you explain the orexin system’s role in MDD to patients? Review the rationale, explore SORAs as an adjunctive strategy, and build confidence in translating this into real clinical conversations. 🔗 mdsc.pe/4sqmmvO

⚠️ Constipation ≠ IBS-C If you’re not separating the two correctly, you’re likely missing better treatment options. Get clear on diagnosis + evidence-based prescriptions that align with patient needs. 📍 mdsc.pe/3PiKhyn